For patients using insulin as part of their diabetes treatment, this is fantastic news, especially among those with needle-phobia, complex treatments and adherence challenges.
What is Awiqli used for? Insulin icodec 700 units/mL solution is a once-weekly treatment of adults with diabetes to improve glycemic control. It can be used in both type 1 and 2 diabetes. In patients with type 1 diabetes, insulin icodec must be used in regimens containing rapid/short-acting insulin as mealtime insulin. In patients with type 2 diabetes it can be used in combination with oral antidiabetic agents when treatment with oral antidiabetic agents does not achieve adequate glycemic control.
Administration is subcutaneous once-weekly into the thigh, upper arm or abdomen. The injection site should be rotated in order to reduce the risk of lipodystrophy or skin lumps. It can be given on any day of the week at any time of day, but preferably on the same day each week.
The most common side effect is hypoglycemia (low blood sugar) with maximum glucose lowering effect occurring during days 2–4 of the weekly dosing cycle. Other side effects include injection site reactions and weight gain which are similar to other insulins.
Dosing varies in different individuals based on their current regimen and presence or absence of basal insulin in their treatment. Based on clinical trials insulin icodec is at least as effective at managing diabetes as other basal insulin analogues (i.e. Lantus, Levemir) if not better.
So, if you're a diabetic, do you think once-weekly insulin would be helpful for you? Feel free to share your thoughts with us and as always hit that like button and leave us a comment.
Happy reading!
References:
Comments